19
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567.
Regulatory Information RX
With a dosage strength EQ 300MG BASE
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug Yes
Approved since 2006-10-16
Therapeutic Equivalence (TE) Code AB
18
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567.
Regulatory Information DISCN
With a dosage strength EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug Yes
Approved since 2003-06-20
17
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567.
Regulatory Information RX
With a dosage strength EQ 200MG BASE
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug Yes
Approved since 2003-06-20
Therapeutic Equivalence (TE) Code AB
16
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567.
Regulatory Information DISCN
With a dosage strength EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route CAPSULE; ORAL
Reference Listed Drug Yes
Approved since 2003-06-20